|
Gleason 7 (3+4)
mean ± SD
or
n/N (%)
|
Gleason 7 (4+3)
mean ± SD
or
n/N (%)
|
p value |
Age (years) |
64.3 ± 6.7 |
62.9 ± 10.6 |
0.38 |
Preoperative serum PSA |
11.0 ± 3.3 |
11.8 ± 6.05 |
0.01 |
≤ 4,00ng/ml |
01/39 (03) |
01/16 (06) |
0.04
|
> 4,00 and ≤ 9,99ng/ml |
28/39 (72) |
05/16 (32) |
> 9,99ng/ml |
10/39 (26) |
10/16 (62) |
Percentage of gland involvement by carcinoma |
16 ± 11.4 |
19 ± 11.7 |
0.29 |
≤ 10% |
27/76 (23) |
07/30 (35) |
0.14
|
> 10% and ≤ 20% |
22/76 (29) |
09/30 (30) |
> 20% and ≤ 30% |
20/76 (26) |
07/30 (23) |
> 30% and ≤ 40% |
03/76 (04) |
06/30 (20) |
> 60% and ≤ 80% |
07/76 (05) |
01/30 (03) |
Tumor volume (ml) |
12.0 ± 3.48 |
12.0 ± 3.47 |
0.6 |
Positive circumferential surgical margin |
18/76 (23) |
09/30 (30) |
0.3 |
Positive basal surgical margin |
04/76 (05) |
03/30 (10) |
0.3 |
Positive apical surgical margin |
02/76 (03) |
02/30 (07) |
0.3 |
Extraprostatic extension |
15/76 (20) |
11/30 (38) |
0.04 |
Seminal vesicle invasion |
03/76 (04) |
05/30 (17) |
0.02 |
Tertiary Gleason 5 |
07/76 (09) |
02/30 (07) |
0.8 |